What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Surgery
- Cardiology
Internal medicine, Cardiology, Surgery, Percutaneous coronary intervention and Myocardial infarction are her primary areas of study.
Her Internal medicine study frequently draws parallels with other fields, such as Guideline.
She has researched Cardiology in several fields, including Ambulatory, Blood pressure and Denervation.
Her biological study spans a wide range of topics, including Angioplasty and MEDLINE.
In her study, Thienopyridine is inextricably linked to Platelet aggregation inhibitor, which falls within the broad field of Percutaneous coronary intervention.
Her work deals with themes such as Mace and Sirolimus, which intersect with Stent.
Her most cited work include:
- Clinical End Points in Coronary Stent Trials A Case for Standardized Definitions (4225 citations)
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions (2754 citations)
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention (1593 citations)
What are the main themes of her work throughout her whole career to date?
Laura Mauri mainly investigates Internal medicine, Cardiology, Surgery, Percutaneous coronary intervention and Myocardial infarction.
Her study in Stent, Randomized controlled trial, Coronary artery disease, Aspirin and Platelet aggregation inhibitor falls within the category of Internal medicine.
In general Cardiology, her work in Thienopyridine, Clopidogrel and Revascularization is often linked to In patient linking many areas of study.
Her Surgery research is multidisciplinary, incorporating elements of Clinical trial and Angioplasty.
Her research integrates issues of Conventional PCI, Acute coronary syndrome, Intensive care medicine, Emergency medicine and Ticlopidine in her study of Percutaneous coronary intervention.
Her work carried out in the field of Myocardial infarction brings together such families of science as Stroke, Thrombosis and Diabetes mellitus.
She most often published in these fields:
- Internal medicine (63.18%)
- Cardiology (55.02%)
- Surgery (41.63%)
What were the highlights of her more recent work (between 2016-2021)?
- Internal medicine (63.18%)
- Cardiology (55.02%)
- Percutaneous coronary intervention (38.70%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Internal medicine, Cardiology, Percutaneous coronary intervention, Myocardial infarction and Randomized controlled trial.
Her Cardiology research integrates issues from Pharmacotherapy, DUAL and MEDLINE.
Her Percutaneous coronary intervention study combines topics in areas such as Surgery, Ticlopidine, Conventional PCI and Intensive care medicine.
Her Myocardial infarction research includes themes of Stroke, Stent, Diabetes mellitus and Coronary stenting.
Clinical endpoint and Sirolimus is closely connected to Target lesion in her research, which is encompassed under the umbrella topic of Stent.
Her Randomized controlled trial research incorporates themes from Odds ratio, Ambulatory, Clinical trial and Angioplasty.
Between 2016 and 2021, her most popular works were:
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). (1354 citations)
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease (486 citations)
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial (302 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Gene
Her primary areas of study are Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Ambulatory.
Her is involved in several facets of Internal medicine study, as is seen by her studies on Aspirin and Heart failure.
The Cardiology study combines topics in areas such as MEDLINE and Cardiothoracic surgery.
In her study, Clopidogrel is strongly linked to Coronary artery disease, which falls under the umbrella field of Myocardial infarction.
Her Percutaneous coronary intervention research is multidisciplinary, relying on both Stent, Surgery and Conventional PCI.
Her Ambulatory research incorporates elements of Anesthesia, Randomized controlled trial and Blood pressure.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
